The Very Favorable Metastatic Renal Cell Carcinoma (Mrcc) Risk Group: Data From The International Metastatic Rcc Database Consortium (Imdc).
JOURNAL OF CLINICAL ONCOLOGY(2021)
摘要
339Background: The IMDC criteria have been used as a prognostic tool for patients with mRCC receiving single agent VEGF-targeted drugs, and more recently combination immuno-oncology (IO) +/- VEGF-t...
更多查看译文
关键词
Renal Cell Carcinoma
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要